Detalhe da pesquisa
1.
Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.
Ann Hematol
; 98(9): 2063-2072, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31312928
2.
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
Am J Hematol
; 96(6): E207-E210, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725366
3.
Tracking myeloid malignancies by targeted analysis of successive DNA methylation at neighboring CG dinucleotides.
Haematologica
; 104(8): e349-e351, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705100
4.
Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.
Sci Rep
; 12(1): 870, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042906
5.
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCO.
Leukemia
; 36(10): 2519-2527, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071100
6.
Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells.
Leukemia
; 35(10): 2936-2947, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002031
7.
Associations of myeloid hematological diseases of the elderly with osteoporosis: A longitudinal analysis of routine health care data.
Leuk Res
; 69: 81-86, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29705535
8.
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-ß superfamily inhibitors.
Semin Hematol
; 54(3): 141-146, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958287
9.
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts.
Curr Hematol Malig Rep
; 11(6): 416-424, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595736
10.
Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications.
Curr Pharm Des
; 22(16): 2323-32, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26916019
11.
Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents.
Leukemia
; 34(4): 1182-1186, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796915
12.
Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2.
Leuk Lymphoma
; 58(5): 1271-1272, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659716
13.
Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation.
Autophagy
; 8(3): 350-63, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22377621